Skye Bioscience Inc. will get a new trial on an executive’s claims that she was fired for blowing the whistle on the former CEO’s deceptive public communications about the company’s glaucoma treatment.
A trial judge wrongly admitted evidence of a former Skye board member’s guilty plea and Securities and Exchange Commission judgment, a divided US Court of Appeals for the Ninth Circuit said Tuesday. That evidence had only slight probative value, yet was highly prejudicial to Skye, the 2-1 panel said.
The trial judge permitted the jury to impute the former board member’s misconduct to the company even though it ...
AI-powered legal analytics, workflow tools and premium legal & business news.
Log in to keep reading or access research tools.
Rochester, N.Y. — A Greece man faces federal charges for conspiracy, wire fraud, aggravated identity theft and money laundering, the U.S. Attorney's Office for the Western District of New York ann...